Often the question is asked “what were your top postings during the previous year. This is an intriguing question since I don’t know myself until I review the postings at the end of each year. With an accumulation of over 70,000 views, it is of interest to determine what you, the viewers, deemed to be the most important.
I have now sorted through the various postings from this past year and find those items listed below to have warranted the most views. Interestingly, four of the five top postings involved FDA issues and most of those involved either a Form FDA 483 or a Warning Letter. The fifth discusses USP 61/62 and “Frequently Asked Questions”.
Rounding out the top ten views were more FDA and USP issues. Interestingly, within this group of top views was a posting regarding upcoming webinars, seminars and conferences which was periodically updated as new events were added. I applaud each of you for your interest in furthering your education and training.
2) USP 61/62 Frequently Asked Questions
3) Ben Venue Received Yet Another Form FDA 483
4) FDA Issues — Media Growth Promotion Studies McNEIL-PPC, Deltex Pharma, Ribbon Pharma & Chemical, Columbia Presbyterian Medical Center
5) FDA Issues Warning Letter for Clinical Supply Manufacturing Facilities